EUCTR2006-001409-27-IT进行中（未招募）不适用
Pegfilgrastim versus filgrastim after high-dose chemotherapy followed by autologous peripheral blood stem cell, in patients with hematologic and solid tumors a randomized phase II study - ND
ISTITUTO CLINICO HUMANITAS0 个研究点目标入组 80 人开始时间: 2006年10月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 61619; 18 years Normal cardiac, hepatic renal and lung function Patients with hematological neoplasia or solid tumor treated with High-dose chemotherapy with autologous peripheral stem cell reinfusion The CD34 number must be at least 3 x106/kg Written consent signed by the patient
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Use concomitantly of experimental drugs Psicological, social condition which can hinder the study compliance Active infection at time of high-dose chemotherapy
研究者
相似试验
已完成
2 期
Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyHematological NeoplasmsTumorsNCT00410696Armando Santoro, MD80
尚未招募
3 期
Comparison of the effect of pegfilgrastim with filgrastim on the neutrophil count of cancer patients under chemotherapy.IRCT20180119038433N3Semnan University of Medical Sciences60
已完成
2 期
The comparison of effects of two drugs in neutropenic patientseutropenia.NeutropeniaIRCT201205279875N1Cinnagen Drug Corporation66
已完成
2 期
Comparison of the effect of two doses of filgrastim in the treatment of neutropeniaIRCT20180103038196N8Gorgan University of Medical Sciences60
已完成
2 期
Pegfilgrastim compared with filgrastim in patients with acute myeloid leukemia after chemotherapyIRCT20151020024625N8Semnan University of Medical Sciences58